• July 30, 2008
• July 21, 2008
• July 14, 2008
• July 7, 2008
• July 2, 2008

Welcome to New SoCalBio Members

• Inscent, Inc. (Irvine)

Inscent was founded to capitalize on recent findings about how an insect interacts with its environment through taste and smell. The company's technology has immediate applications in disciplines ranging from insect pest control to commercial pharmaceutical production and design, disease control products, and sensor products for manufacturing, quality control, military, and homeland security applications .. Learn more 

• MiCardia (Irvine)

Formed in November 2004, MiCardia is an early stage venture dedicated to designing, developing and commercializing minimally invasive methods to treat heart valve disease - Mitral Valve Regurgitation (MR), Tricuspid Valve Regurgitation and Congestive Heart Failure (CHF) ... Learn more

• U. S. Demand for Orthopedic Implants to Approach $22 Billion in 2012

According to a recent market report, demand for orthopedic implants in the United States is expected to increase 8.9% annually to nearly $22 billion in 2012. Each of the four major orthopedic product segments-reconstructive joint replacements, spinal implants, orthobiologics, and trauma implants-is expected to provide strong growth opportunities... Learn more

• Medtech Manufacturers Invest to Meet Growing
  Diabetes Market

According to Patrick Driscoll, publisher of MedMarkets newsletter and president of MedMarket Diligence LLC (Foothill Ranch, CA), a research firm focused on advanced medical technologies, the global market for diabetes monitoring and therapy is set to surpass $37 billion by 2010. "There are few markets in the device industry that have the combination of a large and growing patient population, well established products and technologies, and opportunity for continued product and market development as in the diabetes market," says Driscoll ... Learn more

• States Clamp Down on Online Genetic Testing

Two of the most populous states in the U.S. -- California and New York -- have sent warning shots to companies offering genetic testing services via the Internet. The companies have been warned that they are not complying with state laws and that they must take certain actions to demonstrate their compliance ... See list of companies which got warning letters.

Company Headlines

• Aeolus Pharmaceuticals (Laguna Niguel):
• Aeolus Pharmaceuticals Completes Senior Convertible Debt Financing
• Allergan (Irvine):
• Cosmetic Patients Go First Class, While Others Sit in Dermatology Coach
• Amgen (Thousand Oaks):
• Amgen Licenses Molecule for the Treatment of Chronic and Neuropathic Pain to Ortho-McNeil-Janssen Pharmaceuticals, Inc.
• Amgen Issues Statement in Response to Revised ESA Labeling Received from the FDA
• FDA Delivers Another Blow to Amgen's Anemic Drug Sales
• FDA orders safety-related change for anemia drug: Amgen's Aranesp and Procrit not appropriate for some cancer patients
• Bioness (Valencia):
• Bioness Announces NESS H200 and L300 Systems to Be Available at 88 HealthSouth Hospitals Nationwide
• Cortex Pharmaceuticals (Irvine):
• Cortex to Provide Top Line Data for CX717 Clinical Trial for the Prevention of Opiate-Induced Respiratory Depression in Humans
• IRIS International (Chatsworth):
• IRIS International Elects Edward F. Voboril to Board of Directors
• NeoCell (Newport Beach):
• Reversitall with Resveratrol Stimulates Anti-Aging Enzyme
• Obagi Medical Products (Long Beach):
• Obagi Medical Products' 3-Step Acne System Provides an Effective Approach to Treating Acne without Topical Antibiotic Exposure